Core Insights - Selectis Health, Inc. has executed a definitive Purchase and Sale Agreement to sell two skilled nursing facilities in Georgia for $13.18 million, with a target completion date of February 1, 2026 [1][3] Group 1: Transaction Details - The properties sold include Providence of Sparta Health & Rehab and Warrenton Health & Rehabilitation, purchased by Journey Propco LLC entities for $13,175,000, subject to customary adjustments [1] - Following the transaction, Selectis will continue to operate existing facilities in Georgia, including Eastman Healthcare & Rehabilitation and Glen Eagle Nursing & Rehabilitation [2] Group 2: Operational Improvements - The CEO highlighted that the sale reflects operational improvements and aims to strengthen the company's balance sheet, retire debt, and generate positive cash flow [3] - Significant improvements in occupancy rates were noted at the Southern Hills facility, increasing from 55-61% in 2024 to 68-71% in 2025, alongside enhanced service quality [4] - At the Park Place facility, patient numbers increased from 48 to 65, with skilled patients rising from 1 to 10, indicating improved occupancy and quality [5] Group 3: Quality Measurement and Compliance - The company has seen improvements in CMS quality measurement ratings across its facilities, reflecting better regulatory compliance and resident outcomes [6] - The resolution of outstanding bed taxes in Georgia, amounting to $1,484,703.19, has also contributed to improved cash flow [7] Group 4: Strategic Growth and Market Presence - Selectis Health upgraded its common stock to OTCQB in June 2025, enhancing visibility and liquidity [8] - The company aims to deepen its market presence in the Southcentral and Southeastern U.S. to better serve the aging population [9]

Company Overview - Encompass Health Corporation is the largest owner and operator of inpatient rehabilitation hospitals in the U.S., with approximately 166 facilities across 38 states [3] - The company provides intensive post-acute care, including physical, occupational, respiratory, and speech therapy for patients recovering from major illnesses and injuries [3] Allegations of Wrongdoing - An article published by The New York Times on July 15, 2025, raised patient safety concerns at Encompass rehabilitation hospitals, stating that the company owns 34 of the 41 inpatient rehab facilities flagged by Medicare for having "statistically significantly worse rates of potentially preventable readmissions" [4] - Specific incidents mentioned include fatal carbon monoxide poisoning, medication errors, and bed alarm failures [4] Market Reaction - Following the publication of the article, Encompass's stock price fell by $12.39 per share, or 10.35%, closing at $107.28 per share on July 15, 2025 [5]